Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: K22 CA215828
National Cancer Institute
Grant: R37 CA230042
U.S. Department of Defense
Grant: W81XWH2110786
National Cancer Institute
Grant: R37 CA251216
National Institutes of Health
Grant: 5K22CA215828-03
Identifying Proliferation-Independent Metabolic Vulnerabilities in Cancer
National Institutes of Health
Grant: 5R37CA251216-03
Targeting Serine Auxotrophy in Luminal Breast Cancer
National Institutes of Health
Grant: 4R37CA230042-06
Investigation of NRF2-Dependent Metabolic Liabilities
Fields of Study
Keywords